RSS

cancer medicines

Hamburg-based private platform company, Topas Therapeutics, has signed a multi-year agreement with Boehringer Ingelheim to collaborate in the field of antigen-specific tolerance induction. Read more

News

The inaugural conference from Bionow, exploring the strengths in the discovery, development and manufacture of cancer medicines in the North of England, is to be hosted at Alderley Park later on this month (27 February). Read more

News

A survey of leading pharmaceutical businesses in the UK has led to a stark warning about a potential decrease in access to new medicines in the UK. Read more

News